期刊文献+

HPLC法测定犬体内罗格列酮药物动力学参数 被引量:2

Determination of Pharmacological Parameters for Rosiglitazone in Dogs by HPLC
下载PDF
导出
摘要    目的-研究马来酸罗格列酮在犬体内的药动学特点。方法-以乙腈固相提取, HPLC法测定马来酸罗格列酮的血浆药物浓度; 以3P97软件计算磷酸罗格列酮药动学参数。结果与结论-马来酸罗格列酮在犬体内呈现1级吸收权重为1的一室模型规律; 其主要的药动学参数为 V (c) 约 0 4231 mg/kg/ (μg·ml-1), T1/2(ke)约107 6 min, CL约0 0027 mg·kg-1·min/ ( g·ml-1)。 Objective To determine the pharmacological parameters of rosiglitazone in dogs. Methods The concentration of rosiglitazone in dog plasma was determined by HPLC and the pharmacological parameters were calculated by Practical Pharmacokinetic Program Version 97(3P97) soft. Results and Conclusions The results showed that the pharmacological characteristics of rosiglitazone in dog were one order absorption and two apartments distribution. V(c) was about 0.4231 mg/kg/(μg· ml^(-1)),T (1/2(ke)) about 107.6 min, CL about 0.0027 mg·kg^(-1)·min/(μg·ml^(-1)).
出处 《四川动物》 CSCD 北大核心 2005年第1期90-93,共4页 Sichuan Journal of Zoology
关键词 马来酸罗格列酮 HPLC 高效液相色谱 药物动力学参数 降血糖药 rosiglitazone maleate HPLC pharmacokinetics dog
  • 相关文献

参考文献6

  • 1魏淑香,张振清.反相高效液相色谱法测定血浆中罗格列酮的含量[J].药物分析杂志,2001,21(5):365-367. 被引量:11
  • 2Sorbera LA,et al. Rosiglitazone maleate [J]. Drugs of Future,1998,23(9):977.
  • 3Miller AK GR, et al. The effect of acarbose on the pharmacokinetics of rosiglitazone [J]. Eur J Clin Pharmacol,2001,57:105-109.
  • 4Freed MI, et al. Systemic exposure to rosiglitazone is unaltered by food [J]. Eur J Clin Pharmacol,1999,55:53-56.
  • 5Muxlow AM, et al. Automated high-performance liquid chromatographic for determination of rosiglitazone in plasma [J]. J Chromatography B,2001,752:77.
  • 6冯浩,王智民,陈大为.马来酸罗格列酮胃漂浮型缓释片的研究[J].中国药科大学学报,2002,33(3):196-199. 被引量:16

二级参考文献4

共引文献24

同被引文献13

  • 1杨俊卿,邱红梅,尚京川,周岐新,高丽佳,徐蜀远.依替膦酸罗格列酮与马来酸罗格列酮的生物等效性研究[J].第三军医大学学报,2006,28(23):2343-2345. 被引量:3
  • 2胡湘南.噻唑烷二酮金属盐类药物肠溶制剂及其制备方法[P].中国专利:CN101327198.2008-12-24.
  • 3Moore GB, Chapman H, Holder JC, et al. Differential reg- ulation of adipocytokine mRNAs by rosiglitazone in db/db mice[J]. Biochem Biophys Res Commun, 2001, 286 (4):735.
  • 4Kim KA, Park JY. Simple and extractionless high-peform- ance liquid chromatographic determination of rosigli- tazone in human plasma and application to pharmacokinet- ics in humans[J]. Biomedical Chromatography, 2004, 18 (8):613.
  • 5SORBERA L A, RABASSEDA X, CASTANER J, et al. Rosiglitazone maleate [ J ]. Drugs Future, 1998, 23 (9) : 977 - 985.
  • 6MUXLOW A M, FOWLES S, RUSSELL P. Automated high-performance liquid chromatography method for the determination of rosiglitazone in human plasma [J]. J Chromatogr B Biomed Sci Appl, 2001,752(1): 77-84.
  • 7MILLER A K, INGLIS A M, CULKIN K T, et al. The effect of acarbose on the phannacokinetics of rosiglitazone[ J]. Eur J Clin Phannacol, 2001, 57(2) : 105 - 109.
  • 8FREED M I, ALLEN A, JORKASKY D K, et al. Systemic exposure to rosiglitazone is unaltered by food [ J]. Eur J Clin Pharmacol, 1999, 55(1): 53 -56.
  • 9甘勇军,吴禄春,方大树,胡湘南,秦黄英,黄波.罗格列酮钠肠溶片的制备及质量控制[J].中国药房,2009,20(10):773-774. 被引量:3
  • 10甘勇军,吴禄春,方大树,胡湘南.罗格列酮钠肠溶片的体外释放特性[J].中国医院药学杂志,2009,29(14):1159-1161. 被引量:5

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部